14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.81 $4.85 Wednesday, 1st May 2024 NVAX stock ended at $4.67. This is 7.85% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 11.89% from a day low at $4.29 to a day high of $4.80.
90 days $3.53 $6.05
52 weeks $3.53 $11.36

Historical Novavax Inc prices

Date Open High Low Close Volume
Oct 31, 2023 $6.49 $6.83 $6.36 $6.66 5 564 897
Oct 30, 2023 $6.32 $6.69 $6.32 $6.52 4 121 023
Oct 27, 2023 $6.50 $6.54 $6.30 $6.35 3 560 387
Oct 26, 2023 $6.20 $6.48 $6.15 $6.42 5 447 517
Oct 25, 2023 $6.23 $6.42 $6.16 $6.27 4 189 620
Oct 24, 2023 $6.34 $6.49 $6.09 $6.25 4 596 123
Oct 23, 2023 $6.35 $6.59 $6.10 $6.16 5 985 148
Oct 20, 2023 $6.13 $6.59 $6.02 $6.43 6 824 107
Oct 19, 2023 $6.57 $6.57 $6.00 $6.11 6 783 429
Oct 18, 2023 $6.40 $6.56 $6.33 $6.47 5 982 227
Oct 17, 2023 $6.55 $6.77 $6.41 $6.45 6 938 778
Oct 16, 2023 $6.97 $7.21 $6.38 $6.63 14 888 171
Oct 13, 2023 $7.40 $7.40 $6.81 $7.05 12 093 053
Oct 12, 2023 $7.60 $7.63 $7.20 $7.45 8 508 210
Oct 11, 2023 $7.43 $8.12 $7.43 $7.63 10 198 537
Oct 10, 2023 $7.22 $7.48 $7.21 $7.38 4 686 106
Oct 09, 2023 $7.43 $7.53 $7.15 $7.18 6 434 073
Oct 06, 2023 $7.00 $7.73 $6.99 $7.62 11 816 256
Oct 05, 2023 $7.25 $7.31 $6.91 $7.13 8 012 766
Oct 04, 2023 $7.08 $7.78 $6.97 $7.33 13 893 392
Oct 03, 2023 $7.08 $8.15 $6.73 $7.67 28 597 343
Oct 02, 2023 $7.24 $7.31 $7.04 $7.09 5 100 958
Sep 29, 2023 $7.29 $7.68 $7.16 $7.24 8 089 672
Sep 28, 2023 $7.19 $7.27 $7.01 $7.16 3 476 331
Sep 27, 2023 $7.18 $7.38 $7.03 $7.19 4 095 277
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT